• 219 Citations
  • 10 h-Index
20072019
If you made any changes in Pure these will be visible here soon.

Research Output 2007 2019

  • 219 Citations
  • 10 h-Index
  • 36 Article
  • 11 Review article
  • 2 Letter
Filter
Article
2019
9 Citations (Scopus)

BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy

Mio, C., Gerratana, L., Bolis, M., Caponnetto, F., Zanello, A., Barbina, M., Di Loreto, C., Garattini, E., Damante, G. & Puglisi, F., Feb 15 2019, In : International Journal of Cancer. 144, 4, p. 755-766 12 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Recombinational DNA Repair
DNA Damage
Neoplasms
Proteins
1 Citation (Scopus)

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis

Giuliano, M., Schettini, F., Rognoni, C., Milani, M., Jerusalem, G., Bachelot, T., De Laurentiis, M., Thomas, G., De Placido, P., Arpino, G., De Placido, S., Cristofanilli, M., Giordano, A., Puglisi, F., Pistilli, B., Prat, A., Del Mastro, L., Venturini, S. & Generali, D., Oct 1 2019, In : The Lancet Oncology. 20, 10, p. 1360-1369 10 p.

Research output: Contribution to journalArticle

letrozole
Hormones
Breast Neoplasms
Drug Therapy
Therapeutics
4 Citations (Scopus)

Eribulin in the treatment of advanced breast cancer: Real-world scenario from 39 Italian centers - ESEMPiO study

Barni, S., Livraghi, L., Morritti, M., Vici, P., Michelotti, A., Cinieri, S., Fontanella, C., Porcu, L., Del Mastro, L. & Puglisi, F., Jan 1 2019, In : Future Oncology. 15, 1, p. 33-44 12 p.

Research output: Contribution to journalArticle

eribulin
Breast Neoplasms
Safety
Therapeutics
Italy
2018

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)

Gori, S., Puglisi, F., Cinquini, M., Pappagallo, G., Frassoldati, A., Biganzoli, L., Cortesi, L., Fiorentino, A., Angiolini, C., Tinterri, C., De Censi, A., Levaggi, A. & Del Mastro, L., Aug 1 2018, In : European Journal of Cancer. 99, p. 9-19 11 p.

Research output: Contribution to journalArticle

Medical Oncology
Hormones
Breast Neoplasms
Tamoxifen
Therapeutics

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Gagno, S., D'Andrea, M. R., Mansutti, M., Zanusso, C., Puglisi, F., Dreussi, E., Montico, M., Biason, P., Cecchin, E., Iacono, D., Russo, S., Cinausero, M., Saracchini, S., Gasparini, G., Sartori, D., Bari, M., Collovà, E., Meo, R., Merkabaoui, G., Spagnoletti, I. & 20 others, Pellegrino, A., Gianni, L., Sandri, P., Cretella, E., Vattemi, E., Rocca, A., Serra, P., Fabbri, M. A., Benedetti, G., Foghini, L., Medici, M., Basso, U., Amoroso, V., Riccardi, F., Baldelli, A. M., Clerico, M., Bonura, S., Saggia, C., Innocenti, F. & Toffoli, G., Jan 1 2018, In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

exemestane
Prospective Studies
Breast Neoplasms
Biomarkers
Population

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Gagno, S., D'Andrea, M. R., Mansutti, M., Zanusso, C., Puglisi, F., Dreussi, E., Montico, M., Biason, P., Cecchin, E., Iacono, D., Russo, S., Cinausero, M., Saracchini, S., Gasparini, G., Sartori, D., Bari, M., Collovà, E., Meo, R., Merkabaoui, G., Spagnoletti, I. & 20 others, Pellegrino, A., Gianni, L., Sandri, P., Cretella, E., Vattemi, E., Rocca, A., Serra, P., Fabbri, M. A., Benedetti, G., Foghini, L., Medici, M., Basso, U., Amoroso, V., Riccardi, F., Baldelli, A. M., Clerico, M., Bonura, S., Saggia, C., Innocenti, F. & Toffoli, G., Nov 24 2018, In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

exemestane
Prospective Studies
Breast Neoplasms
Disease-Free Survival
Survival

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Gagno, S., D'Andrea, M. R., Mansutti, M., Zanusso, C., Puglisi, F., Dreussi, E., Montico, M., Biason, P., Cecchin, E., Iacono, D., Russo, S., Cinausero, M., Saracchini, S., Gasparini, G., Sartori, D., Bari, M., Collovà, E., Meo, R., Merkabaoui, G., Spagnoletti, I. & 20 others, Pellegrino, A., Gianni, L., Sandri, P., Cretella, E., Vattemi, E., Rocca, A., Serra, P., Fabbri, M. A., Benedetti, G., Foghini, L., Medici, M., Basso, U., Amoroso, V., Riccardi, F., Baldelli, A. M., Clerico, M., Bonura, S., Saggia, C., Innocenti, F. & Toffoli, G., Jan 1 2018, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

exemestane
Prospective Studies
Breast Neoplasms
Biomarkers
Population

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Gagno, S., D'Andrea, M. R., Mansutti, M., Zanusso, C., Puglisi, F., Dreussi, E., Montico, M., Biason, P., Cecchin, E., Iacono, D., Russo, S., Cinausero, M., Saracchini, S., Gasparini, G., Sartori, D., Bari, M., Collovà, E., Meo, R., Merkabaoui, G., Spagnoletti, I. & 20 others, Pellegrino, A., Gianni, L., Sandri, P., Cretella, E., Vattemi, E., Rocca, A., Serra, P., Fabbri, M. A., Benedetti, G., Foghini, L., Medici, M., Basso, U., Amoroso, V., Riccardi, F., Baldelli, A. M., Clerico, M., Bonura, S., Saggia, C., Innocenti, F. & Toffoli, G., 2018, In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

Pelizzari, G., Arpino, G., Biganzoli, L., Cinieri, S., De Laurentiis, M., Del Mastro, L., Di Leo, A., Gori, S., Guarneri, V., Marchetti, P. & Puglisi, F., 2018, In : BMC Cancer. 18, 1

Research output: Contribution to journalArticle

Atezolizumab for the treatment of breast cancer

Basile, D., Pelizzari, G., Vitale, M. G., Lisanti, C., Cinausero, M., Iacono, D. & Puglisi, F., May 4 2018, In : Expert Opinion on Biological Therapy. 18, 5, p. 595-603 9 p.

Research output: Contribution to journalArticle

Tumors
Breast Neoplasms
T-cells
Immune system
Biomarkers
2 Citations (Scopus)

Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype

Caggiari, L., Miolo, G., Buonadonna, A., Basile, D., Santeufemia, D. A., Cossu, A., Palmieri, G., De Zorzi, M., Fornasarig, M., Alessandrini, L., Canzonieri, V., Lo Re, G., Puglisi, F., Steffan, A., Cannizzaro, R. & De Re, V., Jan 1 2018, In : International Journal of Molecular Sciences. 19, 1, 47.

Research output: Contribution to journalArticle

Haplotypes
Stomach Neoplasms
cancer
Cadherins
Tumors

Comparison of primary breast cancer and paired metastases: Biomarkers discordance influence on outcome and therapy

Ongaro, E., Gerratana, L., Cinausero, M., Pelizzari, G., Poletto, E., Giangreco, M., Andreetta, C., Pizzolitto, S., Di Loreto, C., Minisini, A. M., Mansutti, M., Russo, S., Fasola, G. & Puglisi, F., Apr 1 2018, In : Future Oncology. 14, 9, p. 849-859 11 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Biomarkers
Progesterone Receptors
Breast Neoplasms
Neoplasm Metastasis
1 Citation (Scopus)

Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey

Bonotto, M., Basile, D., Gerratana, L., Pelizzari, G., Bartoletti, M., Vitale, M. G., Fanotto, V., Lisanti, C., Mansutti, M., Minisini, A. M., Aprile, G., De Laurentiis, M., Montemurro, F., Del Mastro, L. & Puglisi, F., Aug 1 2018, In : Breast. 40, p. 45-52 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Surveys and Questionnaires
Hospital Costs
Physiologic Monitoring

Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme

De Carlo, E., Gerratana, L., De Maglio, G., Buoro, V., Cortiula, F., Gurrieri, L., Isola, M., Fasola, G., Puglisi, F., Pizzolitto, S. & Rizzato, S., Dec 15 2018, In : Journal of Neuro-Oncology. 140, 3, p. 559-568 10 p.

Research output: Contribution to journalArticle

Methyltransferases
Glioblastoma
Methylation
DNA
Manuscripts

Determinants of Last-line Treatment in Metastatic Breast Cancer

Cinausero, M., Gerratana, L., De Carlo, E., Iacono, D., Bonotto, M., Fanotto, V., Buoro, V., Basile, D., Vitale, M. G., Rihawi, K., Fasola, G. & Puglisi, F., Jun 2018, In : Clinical Breast Cancer. 18, 3, p. 205-213 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Prescriptions
Decision Making
Multivariate Analysis

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results

De Placido, S., Giuliano, M., Schettini, F., Von Arx, C., Buono, G., Riccardi, F., Cianniello, D., Caputo, R., Puglisi, F., Bonotto, M., Fabi, A., Bilancia, D., Ciccarese, M., Lorusso, V., Michelotti, A., Bruzzese, D., Veneziani, B. M., Locci, M., De Laurentiis, M. & Arpino, G., Apr 2018, In : Breast. 38, p. 86-91 6 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Population
docetaxel
Disease-Free Survival
Therapeutics

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Martel, S., Poletto, E., Ferreira, A. R., Lambertini, M., Sottotetti, F., Bertolini, I., Montemurro, F., Bernardo, A., Risi, E., Zanardi, E., Ziliani, S., Mura, S., Dellepiane, C., Del Mastro, L., Minisini, A. M. & Puglisi, F., Feb 2018, In : Breast. 37, p. 142-147 6 p.

Research output: Contribution to journalArticle

Body Mass Index
Breast Neoplasms
Thinness
Disease-Free Survival
Survival Analysis

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Martel, S., Poletto, E., Ferreira, A. R., Lambertini, M., Sottotetti, F., Bertolini, I., Montemurro, F., Bernardo, A., Risi, E., Zanardi, E., Ziliani, S., Mura, S., Dellepiane, C., Del Mastro, L., Minisini, A. M. & Puglisi, F., 2018, In : Breast. 37, p. 142-147 6 p.

Research output: Contribution to journalArticle

Body Mass Index
Breast Neoplasms
Thinness
Disease-Free Survival
Survival Analysis

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Martel, S., Poletto, E., Ferreira, A. R., Lambertini, M., Sottotetti, F., Bertolini, I., Montemurro, F., Bernardo, A., Risi, E., Zanardi, E., Ziliani, S., Mura, S., Dellepiane, C., Del Mastro, L., Minisini, A. M. & Puglisi, F., 2018, In : Breast. 37, p. 142-147 6 p.

Research output: Contribution to journalArticle

MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme

Gurrieri, L., De Carlo, E., Gerratana, L., De Maglio, G., Macerelli, M., Pisa, F. E., Masiero, E., Aprile, G., Follador, A., Puglisi, F., Fasola, G., Rizzato, S. & Pizzolitto, S., Apr 1 2018, In : Future Oncology. 14, 8, p. 699-707 9 p.

Research output: Contribution to journalArticle

Glioblastoma
Methylation
temozolomide
Disease-Free Survival
Survival
14 Citations (Scopus)

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Malorni, L., Curigliano, G., Minisini, A. M., Cinieri, S., Tondini, C. A., D'Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I. & 2 others, Biganzoli, L. & Di Leo, A., Jan 1 2018, In : Annals of Oncology. 29, 8, p. 1748-1754 7 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Disease Progression
Breast Neoplasms
Confidence Intervals
Disease-Free Survival

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Malorni, L., Curigliano, G., Minisini, A. M., Cinieri, S., Tondini, C. A., D'Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I. & 2 others, Biganzoli, L. & Di Leo, A., Aug 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, 8, p. 1748-1754 7 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Disease Progression
Breast Neoplasms
Confidence Intervals
Disease-Free Survival

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Malorni, L., Curigliano, G., Minisini, A. M., Cinieri, S., Tondini, C. A., D'Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I. & 2 others, Biganzoli, L. & Di Leo, A., Jan 1 2018, In : Annals of Oncology. 29, 8, p. 1748-1754 7 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Disease Progression
Breast Neoplasms
Confidence Intervals
Disease-Free Survival

Prognostic evaluation in palliative care: final results from a prospective cohort study

Ermacora, P., Mazzer, M., Isola, M., Pascoletti, G., Gregoraci, G., Basile, D., De Carlo, E., Merlo, V., Luz, O., Cattaruzza, M., Orlando, A., Bozza, C., Pella, N., Sacco, C. S., Puglisi, F., Fasola, G. & Aprile, G., Jan 1 2018, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Palliative Care
Cohort Studies
Prospective Studies
Survival
Delivery of Health Care
69 Citations (Scopus)

Tailoring adjuvant endocrine therapy for premenopausal breast cancer

Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Ciruelos, E., Burstein, H. J., Bonnefoi, H. R., Bellet, M., Martino, S., Geyer, C. E., Goetz, M. P., Stearns, V., Pinotti, G., Puglisi, F., Spazzapan, S., Climent, M. A. & 16 others, Pavesi, L., Ruhstaller, T., Davidson, N. E., Coleman, R., Debled, M., Buchholz, S., Ingle, J. N., Winer, E. P., Maibach, R., Rabaglio-Poretti, M., Ruepp, B., Di Leo, A., Coates, A. S., Gelber, R. D., Goldhirsch, A. & Regan, M. M., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 122-137 16 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Breast Neoplasms
Therapeutics
Recurrence

Tailoring adjuvant endocrine therapy for premenopausal breast cancer

Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Ciruelos, E., Burstein, H. J., Bonnefoi, H. R., Bellet, M., Martino, S., Geyer, C. E., Goetz, M. P., Stearns, V., Pinotti, G., Puglisi, F., Spazzapan, S., Climent, M. A. & 16 others, Pavesi, L., Ruhstaller, T., Davidson, N. E., Coleman, R., Debled, M., Buchholz, S., Ingle, J. N., Winer, E. P., Maibach, R., Rabaglio-Poretti, M., Ruepp, B., Di Leo, A., Coates, A. S., Gelber, R. D., Goldhirsch, A. & Regan, M. M., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 122-137 16 p.

Research output: Contribution to journalArticle

exemestane
Tamoxifen
Breast Neoplasms
Therapeutics
Recurrence

Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: Clinicopathological correlations

Iacono, D., Cinausero, M., Gerratana, L., Angione, V., Scott, C. A., De Maglio, G., Pizzolitto, S., Di Loreto, C., Puglisi, F., Fasola, G. & Minisini, A. M., Dec 1 2018, In : Melanoma Research. 28, 6, p. 547-554 8 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Cyclooxygenase 2
Melanoma
Ligands
Skin

Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study: Complementary and alternative medicine in oncology

Bozza, C., Gerratana, L., Basile, D., Vitale, M. G., Bartoletti, M., Agostinetto, E., Russo, S., Follador, A., De Carlo, E., Pella, N., Sottile, R., Fasola, G. & Puglisi, F., Oct 1 2018, In : Journal of Cancer Research and Clinical Oncology. 144, 10, p. 2029-2047 19 p.

Research output: Contribution to journalArticle

Complementary Therapies
Neoplasms
2017

Determinants of Last-line Treatment in Metastatic Breast Cancer

Cinausero, M., Gerratana, L., De Carlo, E., Iacono, D., Bonotto, M., Fanotto, V., Buoro, V., Basile, D., Vitale, M. G., Rihawi, K., Fasola, G. & Puglisi, F., Jan 1 2017, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Prescriptions
Decision Making
Multivariate Analysis
16 Citations (Scopus)

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies

Lambertini, M., Ceppi, M., Cognetti, F., Cavazzini, G., De Laurentiis, M., De Placido, S., Michelotti, A., Bisagni, G., Durando, A., Valle, E., Scotto, T., De Censi, A., Turletti, A., Benasso, M., Barni, S., Montemurro, F., Puglisi, F., Levaggi, A., Giraudi, S., Bighin, C. & 3 others, Bruzzi, P., Del Mastro, L. & MIG and GIM study groups, Jan 2017, In : European Journal of Cancer. 71, p. 34-42 9 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Amenorrhea
Drug Therapy
Confidence Intervals
16 Citations (Scopus)

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Lambertini, M., Ceppi, M., Cognetti, F., Cavazzini, G., De Laurentiis, M., De Placido, S., Michelotti, A., Bisagni, G., Durando, A., Valle, E., Scotto, T., De Censi, A., Turletti, A., Benasso, M., Barni, S., Montemurro, F., Puglisi, F., Levaggi, A., Giraudi, S., Bighin, C. & 2 others, Bruzzi, P. & Del Mastro, L., Jan 1 2017, In : European Journal of Cancer. 71, p. 34-42 9 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Amenorrhea
Drug Therapy
Confidence Intervals

Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis

De Angelis, C. D., Di Maio, M. D., Crispo, A., Giuliano, M., Schettini, F., Bonotto, M., Gerratana, L., Iacono, D., Cinausero, M., Riccardi, F., Ciancia, G., Laurentiis, M. D., Puglisi, F., De Placido, S. D. & Arpino, G., 2017, In : Oncotarget. 8, 68, p. 112816-112824 9 p.

Research output: Contribution to journalArticle

Propensity Score
Phenobarbital
Multicenter Studies
Retrospective Studies
Breast Neoplasms
10 Citations (Scopus)

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study

Lambertini, M., Ferreira, A. R., Meglio, A. D., Poggio, F., Puglisi, F., Sottotetti, F., Montemurro, F., Poletto, E., Bernardo, A., Risi, E., Dellepiane, C., Sini, V., Minuti, G., Grasso, D., Fancelli, S. & Mastro, L. D., Dec 1 2017, In : Clinical Breast Cancer. 17, 8, p. 601-610.e2

Research output: Contribution to journalArticle

Cohort Studies
Retrospective Studies
Breast Neoplasms
Survival
Confidence Intervals
10 Citations (Scopus)

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.

Lambertini, M., Ferreira, A. R., Di Meglio, A., Poggio, F., Puglisi, F., Sottotetti, F., Montemurro, F., Poletto, E., Bernardo, A., Risi, E., Dellepiane, C., Sini, V., Minuti, G., Grasso, D., Fancelli, S. & Del Mastro, L., Dec 1 2017, In : Clinical Breast Cancer. 17, p. 601-610.e2

Research output: Contribution to journalArticle

Cohort Studies
Retrospective Studies
Breast Neoplasms
Survival
Confidence Intervals
6 Citations (Scopus)

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, P. & Guarneri, V., Jun 2017, In : Breast Cancer Research and Treatment. 163, 2, p. 295-302 8 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Therapeutics
2007
19 Citations (Scopus)

Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells

Puglisi, F., Andreetta, C., Valent, F., Minisini, A. M., Rijavec, E., Russo, S., Mansutti, M., Cardellino, G., Pizzolitto, S. & Di Loreto, C., Sep 1 2007, In : Anti-Cancer Drugs. 18, 8, p. 883-888 6 p.

Research output: Contribution to journalArticle

Thymidine Phosphorylase
Taxoids
Anthracyclines
Up-Regulation
Breast Neoplasms